|
V.TLT
|
Correct you and Dawg got that right I just read that note at...
|
|
V.TLT
|
5 new patients were evaluable and we got 7 new CR at 90 days, so...
|
|
V.TLT
|
Also a nice 9 patients have been treated since last MD&A in August. ...
|
|
V.TLT
|
The FDA will look at all data and take into account increasing CR as the...
|
|
V.TLT
|
7 out of 7 newly treated patients seem to be CR at 90 days. In August 19 out...
|
|
V.TLT
|
If you were Roger, what would you prefer. An eventual buyout at say 10$ per...
|
|
V.TLT
|
Given a high efficacy and safety after only 2 treatments it should be easy to...
|
|
V.TLT
|
There were 7 pending patients at 90 days last time, plus I hope at least 3...
|
|
V.TLT
|
They're options to buy at 0.25, so they are not shares and they vest over...
|
|
V.TLT
|
Yup Roger and wife Kristina bought close to $700 000 worth of stock from both...
|
|
V.TLT
|
2 extra CR at 450 days would make it to 28% CR. As well, PR patients...
|
|
V.TLT
|
I believe it's another one "follow on" to close around October...
|
|
V.TLT
|
I thought the same thing. Very well expressed Eoganacht. One or more of...
|
|
V.TLT
|
I do believe that there is an extremely good chance of that happening and...
|
|
V.TLT
|
They may expect SP to head quite a bit higher soon enough to have those...
|
|
V.TLT
|
A 5% dilution took us down temporarily almost 30% from 0.35. StevenBirch...
|
|
V.TLT
|
Good. At least company has about $3.6 Million in cash now until at least a...
|
|
V.TLT
|
A small correction as from 1st set of 12 only 6 were NR, not 9, as 3 were CR...
|
|
V.TLT
|
To complete my point, at 90 days if we end up excluding at least 10...
|
|
V.TLT
|
Nice observations. If we only look at the NR patients at 90 days, the...
|